RIDLY/Health corpora/Mental health
Mental health / Feasibility review

Mental Health & Daily Function

Mood, sleep, symptom patterns and daily functioning for longitudinal mental-health research questions.

Request corpus feasibility Review the scope
Available for feasibility inquiries. Data access, cohort coverage and permitted uses require verification before a license is offered.

Define the corpus

Scope a mental-health corpus around patient-reported experiences and daily functioning. Specify the population, assessment measures and intended use so that sensitivity, consent and suitable field coverage can be reviewed together.

Fields to assess

  • Mood and symptom observations
  • Sleep, activity and daily functioning
  • Medication use and reported adherence
  • Eligible patient-reported assessments and journal-derived measures

Field-level coverage, missingness and provenance are confirmed during feasibility review. Listed modalities are not a promise of availability.

Project applications

  • Within-person symptom trajectories
  • Sleep and functioning relationships
  • Treatment-experience research
  • Evaluation of authorized mental-health data models

Data interpretation

Free-text material requires separate privacy and rights review. Diary fields are not represented as validated clinical scales unless the instrument and implementation are verified.

Cohort and delivery specification

Request the condition definition, unique participant count, geography, observation period, follow-up distribution, field coverage and update schedule. The specification distinguishes self-reported observations, device measurements and clinical-record-derived fields.

Clinical coding, measurement units, data dictionaries, missingness and de-identification are reviewed for the proposed delivery. Clinical images and reports are assessed separately from original DICOM studies; genetic test summaries are assessed separately from raw variants, sequencing and omics matrices.

Licensing and due diligence

Annual licenses, defined-project access and refreshes can be discussed after feasibility review. Research, AI evaluation, model training, derivative models, sublicensing and exclusivity require specific written permissions. Patient recontact is not included in an inquiry or implied by a data license.

Source provenance, the legal supplier or controller and its authority to license are disclosed during buyer due diligence. These profiles may draw on overlapping populations; counts are not added across products.

Tell us the cohort you need.

Include conditions, required fields, follow-up and intended use. No patient records are needed to make an inquiry.

Contact RIDLY